Results 171 to 180 of about 218,916 (388)

Cell-surface immunoglobulin and insulin receptor expression in an EBV-negative lymphoma cell line and its EBV-converted sublines. [PDF]

, 1981
G. Spira, Pierre Åman, Naoki Koide, Gunnel Lundin, Georg Klein, K. Hall   +5 more
openalex   +1 more source

Checkmate for EBV-HLH [PDF]

Blood, 2020
Kenneth L. McClain, Nader Kim El-Mallawany   +1 more
openaire   +3 more sources

Is parvovirus B19 infection upsurge in 2023–2024 associated with adverse pregnancy outcome?

Ultrasound in Obstetrics &Gynecology, EarlyView.
ABSTRACT Objective A surge in parvovirus B19 infections has been reported in 2023–2024 across Europe and the USA, raising concerns about the associated perinatal risks. The aim of this study was to compare perinatal outcomes following maternal parvovirus B19 infection during the 2023–2024 period with those from a pre‐2023 cohort.
S. Prasad, A. Khalil, Y. Yinon, N. Regev, R. Brawura‐Biskupski‐Samaha, M. Massoud, N. Mazanowska, F. G. Sileo, F. Prefumo, P. Kosinski, J. Morales Rosello, F. D'Antonio, Collaborators, C. Ozan Ulusoy, D. Mohammed, M. Arora, A. Hegde, E. Klapholz, C. Berkovitz, K. Kosińska‐Kaczyńska, I. Rzucidło‐Szymańska, N. Szymecka‐Samaha, S. Ceffa   +22 more
wiley   +1 more source

An unusually high-titer human anti-Epstein Barr virus (EBV) serum and its use in the study of EBV-specific proteins synthesized in vitro and in vivo. [PDF]

, 1983
C M Edson, L. Cohen, Werner Henle, Jack L. Strominger   +3 more
openalex   +1 more source

Exploring the role of EBV in multiple sclerosis pathogenesis through EBV interactome

Frontiers in Immunology
BackgroundEpstein-Barr virus (EBV) is a known risk factor for multiple sclerosis (MS), even though the underlying molecular mechanisms are unclear and engage multiple immune pathways. Furthermore, the ultimate role of EBV in MS pathogenesis is still elusive.
Chiara Ballerini, Roberta Amoriello, Olfa Maghrebi, Gianmarco Bellucci, Ilaria Addazio, Matteo Betti, Maria Grazia Aprea, Camilla Masciulli, Arianna Caporali, Valeria Penati, Clara Ballerini, Ermelinda De Meo, Emilio Portaccio, Marco Salvetti, Marco Salvetti, Maria Pia Amato, Maria Pia Amato   +16 more
openaire   +3 more sources

CRISPR/Cas9‐edited tumor‐associated immune cells in cancer immunotherapy

VIEW, EarlyView.
Abstract Immuno‐oncology represents an emerging field that has significantly transformed tumor therapeutics, with immune cells serving as the cellular foundations of cancer immunotherapy. Due to its high efficiency and sensitivity, CRISPR/Cas9 genome editing is a highly promising technique for precise and rapid gene modification.
Yuhui Ma, Junxin Chen, Yuan Du, Zhihao Cao, Weizhi Ji, Yuyu Niu, Zebin Yang   +6 more
wiley   +1 more source

Regulated expression of the feline panleukopenia virus P38 promoter on extrachromosomal FPV/EBV chimeric plasmids [PDF]

, 1989
Dahn L. Clemens, J. O. Carlson
openalex   +1 more source

Novel genetic algorithm‐based individual treatment effect scoring model for optimizing decision‐making: Induction chemotherapy in nasopharyngeal carcinoma

VIEW, EarlyView.
To address the limitations of traditional risk‐stratification decision models, this study developed an individualized treatment effect (ITE) scoring model based on a genetic algorithm. By accurately predicting the treatment response to induction chemotherapy and stratifying patients into distinct subgroups, the ITE model holds promise for enhancing ...
Chao Luo, Haojiang Li, Shuchao Chen, Hongchuang Chen, Haoyang Zhou, Shuqi Li, Wenjie Huang, Zhiyin Liang, Guangying Ruan, Shaobo Liang, Yuliang Zhu, Di Cao, Ge Ren, Kit Lan Kou, Xin Yang, Guoyi Zhang, Jun Shen, Hongbo Chen, Lizhi Liu   +18 more
wiley   +1 more source

Nodal T-Follicular Helper Cell Lymphoma, Angioimmunoblastic-Type, Diagnosed in a Patient with Psoriasis Following COVID-19 Vaccination under Adalimumab Treatment: A Causal Association?

Indian Journal of Dermatology
Biologics have expanded the armamentarium for psoriasis, but there has been a growing concern about the risk of lymphoma in patients under tumour necrosis factor (TNF)-α inhibitor and methotrexate.
Chang-Yu Hsieh, Shan-Chi Yu, Jia-Arng Lee, Tsen-Fang Tsai   +3 more
doaj   +1 more source

Epstein-Barr virus, infectious mononucleosis, and posttransplant lymphoproliferative disorders. [PDF]

, 1994
PTLD may be considered as an "opportunistic cancer" in which the immunodeficiency state of the host plays a key role in fostering the environment necessary for abnormal lymphoproliferation.
Nalesnik, MA, Starzl, TE
core